(IBTM) iBonds Dec 2032 Term - Overview
Etf: Treasury, Bonds, ETF, Maturity, 2032
| Risk 5d forecast | |
|---|---|
| Volatility | 3.06% |
| Relative Tail Risk | -0.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.80 |
| Alpha | 4.75 |
| Character TTM | |
|---|---|
| Beta | -0.053 |
| Beta Downside | -0.188 |
| Drawdowns 3y | |
|---|---|
| Max DD | 10.28% |
| CAGR/Max DD | 0.42 |
Description: IBTM iBonds Dec 2032 Term December 31, 2025
The iShares iBonds Dec 2032 Term Treasury ETF (IBTM) tracks a market-value-weighted index of U.S. Treasury securities, net of holdings by the Federal Reserve’s System Open Market Account (SOMA). The fund is required to hold at least 80% of its assets in the index’s component securities and at least 90% in U.S. Treasuries that BFA deems appropriate for index tracking, except during the final months before the fund’s scheduled termination.
Key quantitative points to note: as of the latest data, IBTM’s weighted average maturity is approximately 10.5 years, delivering a current yield near 4.2%, which is sensitive to the Fed’s policy rate trajectory. The ETF’s expense ratio stands at 0.15%, modest relative to peers, and its average daily trading volume exceeds 200,000 shares, supporting liquidity. Macro-driven factors such as the U.S. Treasury yield curve steepening or flattening, and inflation expectations, directly influence the fund’s performance and total return.
For a deeper, data-rich analysis of IBTM’s risk-adjusted returns and scenario modeling, you might explore the ValueRay platform for additional insights.
Altman Z''
Beneish M
| DSRI: none (Receivables none/none, Revenue 0.0/0.0) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: none (Revenue 0.0 / 0.0) |
| TATA: none (NI 0.0 - CFO 0.0) / TA none) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of IBTM shares?
Over the past week, the price has changed by -0.09%, over one month by +1.50%, over three months by +0.75% and over the past year by +7.38%.
Is IBTM a buy, sell or hold?
What are the forecasts/targets for the IBTM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
IBTM Fundamental Data Overview February 20, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 525.4m USD (525.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 525.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 525.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 5.72% (E(525.4m)/V(525.4m) * Re(5.72%) + (debt-free company))
Discount Rate = 5.72% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)